Literature DB >> 6121544

The induction of mania. A natural history study with controls.

J L Lewis, G Winokur.   

Abstract

Previous reports have indicated that tricyclic antidepressants (TCAs) induce mania, but the studies suffer from lack of control groups. This study included 137 unipolar and 157 bipolar patients, all having two or more admissions to the same hospital. In many cases, the same patients were treated at one time with TCAs and at another time with no somatic therapy at all. Most patients who switched (20/23) were bipolar. Twenty-seven bipolar patients receiving no treatment had a 41% switch rate (rate/person). They had 32 admissions, and the rate of switch while receiving no treatment was 34% (rate/admission). Twenty-six patients receiving tricyclics had a 28% switch rate; for these, there were 30 admissions and the switch rate was 23%. Thus, it appears that the rate of induction of mania by TCAs is not greater than what one would expect from the natural history of the illness itself. Validity of these findings is attested to by the fact that lithium carbonate and neuroleptic treatment, as expected, significantly prevented the induction of mania.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6121544     DOI: 10.1001/archpsyc.1982.04290030041007

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  17 in total

Review 1.  Bipolar depression: management options.

Authors:  Gin S Malhi; Philip B Mitchell; Shahzad Salim
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

2.  Subthreshold hypomanic symptoms in progression from unipolar major depression to bipolar disorder.

Authors:  Jess G Fiedorowicz; Jean Endicott; Andrew C Leon; David A Solomon; Martin B Keller; William H Coryell
Journal:  Am J Psychiatry       Date:  2010-11-15       Impact factor: 18.112

Review 3.  Drug alternatives to lithium in manic-depressive disorders.

Authors:  D M Shaw
Journal:  Drugs       Date:  1988-09       Impact factor: 9.546

Review 4.  Investigating the mechanism(s) underlying switching between states in bipolar disorder.

Authors:  Jared W Young; Davide Dulcis
Journal:  Eur J Pharmacol       Date:  2015-03-23       Impact factor: 4.432

5.  Adinazolam, a new triazolobenzodiazepine, and imipramine in the treatment of major depressive disorder.

Authors:  J D Amsterdam; M Kaplan; L Potter; L Bloom; K Rickels
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

6.  Antidepressants worsen rapid-cycling course in bipolar depression: A STEP-BD randomized clinical trial.

Authors:  Rif S El-Mallakh; Paul A Vöhringer; Michael M Ostacher; Claudia F Baldassano; Niki S Holtzman; Elizabeth A Whitham; Sairah B Thommi; Frederick K Goodwin; S Nassir Ghaemi
Journal:  J Affect Disord       Date:  2015-06-10       Impact factor: 4.839

7.  Possible manic switch induced by combination of bupropion and electroconvulsive therapy in recurrent unipolar depression: a case series.

Authors:  Sahoo Saddichha; Ashish Soy; Pandey Vibha
Journal:  BMJ Case Rep       Date:  2009-02-26

8.  Genetic features of antidepressant induced mania and hypo-mania in bipolar disorder.

Authors:  Alessandro Serretti; Paola Artioli; Raffaella Zanardi; Cristina Lorenzi; David Rossini; Cristina Cusin; Alessia Arnoldi; Marco Catalano
Journal:  Psychopharmacology (Berl)       Date:  2004-07-10       Impact factor: 4.530

Review 9.  Antidepressant drugs and the emergence of suicidal tendencies.

Authors:  M H Teicher; C A Glod; J O Cole
Journal:  Drug Saf       Date:  1993-03       Impact factor: 5.606

10.  Bipolar Disorder: an impossible diagnosis.

Authors:  Carlo Faravelli; Silvia Gorini Amedei; Maria Alessandra Scarpato; Luca Faravelli
Journal:  Clin Pract Epidemiol Ment Health       Date:  2009-06-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.